HAS
NVO

HBW Advisory Services’s Novo Nordisk NVO Stock Holding History

HBW Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,966
Closed -$405K – 463
2025
Q4 		$405K Sell
7,966
-53
-0.7% -$2.71K 0.04% 305
2025
Q3 		$445K Buy
8,019
+4,576
+133% +$268K 0.05% 282
2025
Q2 		$238K Buy
+3,443
New +$234K 0.03% 356
2024
Q3 		– Sell
-1,799
Closed -$257K – 386
2024
Q2 		$257K Buy
+1,799
New +$238K 0.04% 283

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

HBW Advisory Services's NVO Position: Q1 2026 in Review

HBW Advisory Services sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 7,966 shares — an estimated $405K sold.

HBW Advisory Services first reported a position in NVO in Q2 2024 and held it in 4 quarters. The position peaked at $445K in Q3 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • HBW Advisory Services reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • HBW Advisory Services sold 7,966 Novo Nordisk shares in Q1 2026, an estimated $405K.
  • HBW Advisory Services first reported a position in Novo Nordisk in Q2 2024 and held it in 4 quarters.
  • HBW Advisory Services's Novo Nordisk position peaked at $445K in Q3 2025.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on HBW Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.